Greenwich LifeSciences (GLSI) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $15.32, -0.52% vs the prior close of $15.40.
- Volume 81.30K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GLSI dips 0.5% to $15.32, 3 down days in a row. Closed at $15.32, -0.52% vs the prior close of $15.40. Day range $15.10–$15.60, opened at $15.12.
GLSI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — GLSI dips 0.5% to $15.32, 3 down days in a row
- Closed at $15.32, -0.52% vs the prior close of $15.40. Day range $15.10–$15.60, opened at $15.12.
- Volume was 81.30K shares, 0.6x its 50-day average of 128.80K.
- Price is -7.9% vs its 50-day average ($16.63) and -30.2% vs its 200-day average ($21.93).
- 52-week range $7.78–$34.10; today's close sits at 29% of that range, 55.1% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — GLSI dips 0.6% to $15.40
- Closed at $15.40, -0.65% vs the prior close of $15.50. Day range $15.15–$16.35, opened at $15.25.
- Volume was 137.80K shares, 1.1x its 50-day average of 129.06K.
- Price is -7.3% vs its 50-day average ($16.61) and -29.9% vs its 200-day average ($21.98).
- 52-week range $7.78–$34.10; today's close sits at 29% of that range, 54.8% below the 52-week high.
Oct 13, 2026 — GLSI slides 12.8% to $15.50 on 2.5x normal volume
- Closed at $15.50, -12.77% vs the prior close of $17.77. Day range $14.06–$17.75, opened at $17.50.
- Volume was 317.10K shares, 2.5x its 50-day average of 125.18K — unusually heavy trading.
- Price is -6.6% vs its 50-day average ($16.59) and -29.6% vs its 200-day average ($22.01).
- 52-week range $7.78–$34.10; today's close sits at 29% of that range, 54.5% below the 52-week high.
Oct 12, 2026 — GLSI jumps 7.5% to $17.77
- Closed at $17.77, +7.50% vs the prior close of $16.53. Day range $16.42–$18.00, opened at $16.45.
- Volume was 163.20K shares, 1.3x its 50-day average of 123.62K.
- Price is +7.4% vs its 50-day average ($16.55) and -19.3% vs its 200-day average ($22.02).
- 52-week range $7.78–$34.10; today's close sits at 38% of that range, 47.9% below the 52-week high.
Oct 9, 2026 — GLSI jumps 9.2% to $16.53
- Closed at $16.53, +9.18% vs the prior close of $15.14. Day range $15.20–$16.80, opened at $15.20.
- Volume was 119.40K shares, 1.0x its 50-day average of 123.58K.
- Price is +0.4% vs its 50-day average ($16.46) and -24.9% vs its 200-day average ($22.00).
- 52-week range $7.78–$34.10; today's close sits at 33% of that range, 51.5% below the 52-week high.
Oct 8, 2026 — GLSI dips 1.6% to $15.14, 8 down days in a row
- Closed at $15.14, -1.62% vs the prior close of $15.39. Day range $14.55–$16.14, opened at $15.29.
- Volume was 129.10K shares, 1.0x its 50-day average of 123.04K.
- Price is -7.8% vs its 50-day average ($16.41) and -31.1% vs its 200-day average ($21.98).
- 52-week range $7.78–$34.10; today's close sits at 28% of that range, 55.6% below the 52-week high.
- That makes 8 straight losses.
Oct 7, 2026 — GLSI dips 2.5% to $15.39, 7 down days in a row
- Closed at $15.39, -2.53% vs the prior close of $15.79. Day range $15.00–$16.37, opened at $15.81.
- Volume was 147.20K shares, 1.2x its 50-day average of 123.33K.
- Price is -6.0% vs its 50-day average ($16.37) and -30.0% vs its 200-day average ($21.97).
- 52-week range $7.78–$34.10; today's close sits at 29% of that range, 54.9% below the 52-week high.
- That makes 7 straight losses.
Oct 6, 2026 — GLSI slides 6.6% to $15.79, 6 down days in a row
- Closed at $15.79, -6.62% vs the prior close of $16.91. Day range $15.40–$17.32, opened at $17.02.
- Volume was 113.60K shares, 0.9x its 50-day average of 123.71K.
- Price is -3.3% vs its 50-day average ($16.33) and -28.1% vs its 200-day average ($21.96).
- 52-week range $7.78–$34.10; today's close sits at 30% of that range, 53.7% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — GLSI dips 0.4% to $16.91, 5 down days in a row
- Closed at $16.91, -0.41% vs the prior close of $16.98. Day range $16.26–$17.25, opened at $16.92.
- Volume was 98.70K shares, 0.8x its 50-day average of 124.01K.
- Price is +3.9% vs its 50-day average ($16.28) and -22.9% vs its 200-day average ($21.93).
- 52-week range $7.78–$34.10; today's close sits at 35% of that range, 50.4% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — GLSI dips 2.1% to $16.98, 4 down days in a row
- Closed at $16.98, -2.13% vs the prior close of $17.35. Day range $16.60–$18.25, opened at $17.65.
- Volume was 175.40K shares, 1.4x its 50-day average of 123.93K.
- Price is +4.8% vs its 50-day average ($16.20) and -22.5% vs its 200-day average ($21.90).
- 52-week range $7.78–$34.10; today's close sits at 35% of that range, 50.2% below the 52-week high.
- That makes 4 straight losses.
GLSI latest news & SEC filings
Every SEC filing by or about GLSI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$3.95M (prior year -$3.75M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.27 (prior year -$0.28) (loss narrowed vs Jun 30, 2025)
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Patel Snehal bought 700 shares at $13.10 (≈$9.17K) on Jul 29, 2026
- Patel Snehal bought 1,500 shares at $13.59 (≈$20.39K) on Jul 28, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Patel Snehal bought 1,500 shares at $13.62 (≈$20.43K) on Jul 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Patel Snehal bought 1,100 shares at $12.88 (≈$14.17K) on Jul 24, 2026
- Patel Snehal bought 2,500 shares at $13.14 (≈$32.85K) on Jul 23, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade GLSI
- How much it moves: over the last 20 sessions the average daily move was 3.85% (largest 12.8%). That is a volatile stock.
- Liquidity: about 138.75K shares (≈$2.13M) trade per day on average.
- 52-week position: $15.32 vs a range of $7.78–$34.10 (29% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 13 open-market buys, 0 sales; latest: Snehal Patel bought 700 shares on Jul 29, 2026.
- Latest filings: 10-Q Aug 11, 2026; 10-Q Jun 4, 2026; 10-K Jun 1, 2026.
- Share count: 14.68M shares outstanding (Jul 24, 2026), +7.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
GLSI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 15.12 | 15.60 | 15.10 | 15.32 | 81.30K |
| Oct 14, 2026 | 15.25 | 16.35 | 15.15 | 15.40 | 137.80K |
| Oct 13, 2026 | 17.50 | 17.75 | 14.06 | 15.50 | 317.10K |
| Oct 12, 2026 | 16.45 | 18.00 | 16.42 | 17.77 | 163.20K |
| Oct 9, 2026 | 15.20 | 16.80 | 15.20 | 16.53 | 119.40K |
| Oct 8, 2026 | 15.29 | 16.14 | 14.55 | 15.14 | 129.10K |
| Oct 7, 2026 | 15.81 | 16.37 | 15.00 | 15.39 | 147.20K |
| Oct 6, 2026 | 17.02 | 17.32 | 15.40 | 15.79 | 113.60K |
| Oct 5, 2026 | 16.92 | 17.25 | 16.26 | 16.91 | 98.70K |
| Oct 2, 2026 | 17.65 | 18.25 | 16.60 | 16.98 | 175.40K |
| Oct 1, 2026 | 18.12 | 18.35 | 16.81 | 17.35 | 121.50K |
| Sep 30, 2026 | 18.60 | 19.31 | 18.01 | 18.05 | 145.00K |
| Sep 29, 2026 | 18.78 | 19.21 | 18.20 | 18.38 | 65.70K |
| Sep 28, 2026 | 18.12 | 19.00 | 17.85 | 18.59 | 82.90K |
| Sep 25, 2026 | 18.00 | 18.68 | 18.00 | 18.22 | 66.70K |
| Sep 24, 2026 | 17.46 | 18.15 | 17.30 | 18.10 | 88.10K |
| Sep 23, 2026 | 19.31 | 19.36 | 17.12 | 17.51 | 187.10K |
| Sep 22, 2026 | 18.58 | 20.31 | 18.31 | 19.48 | 122.80K |
| Sep 21, 2026 | 19.20 | 19.24 | 18.12 | 18.59 | 110.10K |
| Sep 18, 2026 | 18.40 | 20.04 | 18.25 | 18.99 | 302.30K |
About Greenwich LifeSciences
Greenwich LifeSciences (GLSI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in STAFFORD, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1799788.
GLSI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Snehal Patel | CEO and CFO | Jul 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Snehal Patel | CEO and CFO | Jul 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 29, 2026 | Snehal Patel | Buy | 700 | $13.10 |
| Jul 28, 2026 | Snehal Patel | Buy | 1,500 | $13.59 |
| Jul 27, 2026 | Snehal Patel | Buy | 1,500 | $13.62 |
| Jul 24, 2026 | Snehal Patel | Buy | 1,100 | $12.88 |
| Jul 23, 2026 | Snehal Patel | Buy | 2,500 | $13.14 |
| Jan 13, 2026 | Snehal Patel | Buy | 1,800 | $29.83 |
| Jan 12, 2026 | Snehal Patel | Buy | 2,900 | $27.54 |
| Dec 31, 2025 | Snehal Patel | Buy | 4,300 | $21.36 |
| Dec 30, 2025 | Snehal Patel | Buy | 2,900 | $21.73 |
| Dec 18, 2025 | Snehal Patel | Buy | 4,100 | $12.62 |
| Nov 25, 2025 | Snehal Patel | Buy | 4,600 | $8.37 |
| Nov 7, 2025 | Snehal Patel | Buy | 10,600 | $8.43 |
| Oct 31, 2025 | Snehal Patel | Buy | 2,300 | $9.26 |
GLSI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-19.36M | -1.43 | $-9.91M |
| Dec 31, 2024 | — | $-17.41M | -1.34 | $-7.27M |
| Dec 31, 2023 | — | $-8.89M | -0.69 | $-6.48M |
| Dec 31, 2022 | — | $-7.83M | -0.61 | $-6.20M |
| Dec 31, 2021 | — | $-4.57M | — | $-4.29M |
Latest balance sheet: total assets $8.88M, total liabilities $5.76M, cash $6.18M (as of Jun 30, 2026).
GLSI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on GLSI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.